Company

Vedanta Biosciences, Inc.

Vedanta Biosciences, Inc., founded in 2010 in Cambridge, develops live biotherapeutic products for gastrointestinal diseases.

About

Founded in 2010 and headquartered in Cambridge, US, Vedanta Biosciences, Inc. develops Live Biotherapeutic Products built from defined bacterial consortia for gastrointestinal diseases, including inflammatory bowel disease and recurrent Clostridium difficile infection. The company has raised a total of USD 106.5 mn across eight deals, and Bernat Olle, its founder, serves as CEO. In August 2026 it raised USD 40 million in venture funding co-led by AMR Action Fund and BNP Paribas Asset Management - Fund of funds, part of a USD 60 million equity and grant round.

7Funding rounds

20Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in